MedPath

Effect of Clear Aligner Attachment Size on Extrusion of Maxillary Lateral Incisors

Not Applicable
Recruiting
Conditions
Orthodontic Appliance Complication
Registration Number
NCT06814262
Lead Sponsor
Virginia Commonwealth University
Brief Summary

Orthodontic treatment has been revolutionized by clear aligner therapy, offering patients a more esthetic and comfortable alternative to traditional braces. In 1999, Align Technology introduced Invisalign. As Invisalign has increased in popularity and demand over the past two decades, clinical trials have shed light on the efficacy of Invisalign treatment. there have been changes in the Invisalign protocol such as introduction of SmartForce features in 2008, such as optimized attachments as well as the implementation of SmartTrack aligner material in 2011. Compared to conventional fixed orthodontic appliances, Invisalign cannot be adjusted on a visit-to visit basis. If ideal tooth movement has not been achieved after completion of the first sequence of aligners, additional trays, known as refinement trays, are required.

Detailed Description

There are various expert theories regarding the most effective methods of extrusion and multiple studies performed in vitro to evaluate the efficacy of different attachment types on the extrusion of lateral incisors, however only one in vivo clinical trial exists. There is a need for more randomized clinical trials that evaluate the effectiveness of different attachment designs for achieving optimal extrusion of lateral incisors. By determining the most effective attachment size for maxillary lateral incisor extrusion, this study can help improve treatment outcomes for orthodontic treatment with clear aligners and serve as a guide to assist clinicians in selecting the most effective attachment design.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients treated with either Comprehensive Invisalign or Invisalign Teen treatment
  • The maxillary arch has less than 6 mm of crowding or spacing
  • Maxillary lateral incisors have a minimum of 0.3 mm of extrusion prescribed in the Tooth Movement Table on the Invisalign ClinCheck for the first set of aligners
  • Maxillary lateral incisors within a normal range of bucco-lingual inclination
  • Patients 12 years of age or older and either the patient or legal guardian are able to give consent
  • Patients confirm good compliance throughout the study period
Exclusion Criteria
  • Patients do not complete all aligners in the first phase as prescribed
  • Poor compliance recorded for aligner wear
  • Restorations placed or oral surgery completed prior to final scan
  • Midcourse intervention to improve tracking such as a bootstrap
  • Maxillary lateral incisors not tracking and noted by minimum of 1 mm of aligner material incisally displaced when aligner fully seated
  • Treatment plans include surgery or extractions
  • Maxillary lateral incisors with pathology and restorations
  • Missing teeth other than third molars
  • Patients with anterior crossbite

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Determine which of three different attachment sizes offers more predictable extrusion of maxillary lateral incisors in subjects treated with clear aligners comparedbaseline until the clear aligner treatment is completed at 20 to 25 weeks

The aim of this prospective, randomized controlled trial is to determine which of three different attachment sizes (gingivally beveled 1x1x3 mm, gingivally beveled 1x1x4 mm, or gingivally beveled 1x1x5 mm) offers more predictable extrusion of maxillary lateral incisors in patients treated with clear aligners compared to control.

Secondary Outcome Measures
NameTimeMethod
Evaluate the accuracy of ClinCheck softwarebaseline until the clear aligner treatment is completed at 20 to 25 weeks

To evaluate the accuracy of ClinCheck software in predicting the three-dimensional final position of the lateral incisor following extrusion using the attachment designs tested.

Trial Locations

Locations (1)

Virginia Commonwealth University

🇺🇸

Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath